TNKS2-DT
gene geneOn this page
Summary
TNKS2-DT (TNKS2 divergent transcript, HGNC:45173) is a long non-coding RNA gene on chromosome 10q23.32.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:45173 |
| Approved symbol | TNKS2-DT |
| Name | TNKS2 divergent transcript |
| Location | 10q23.32 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000228701 |
| Ensembl biotype | lncRNA |
| Entrez | 100507633 |
| RNAcentral | URS000075EAA8 — lncRNA, 706 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 15 lncRNA
ENST00000432246, ENST00000432938, ENST00000662946, ENST00000668345, ENST00000770267, ENST00000770268, ENST00000770269, ENST00000770270, ENST00000770271, ENST00000770272, ENST00000770273, ENST00000770274, ENST00000770275, ENST00000770276, ENST00000770277
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000432246 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001599096 | 91797813 | 91798196 |
| ENSE00001642949 | 91782936 | 91783160 |
Expression profiles
Bgee: expression breadth ubiquitous, 131 present calls, max score 85.97.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.3998 / max 16.2662, expressed in 176 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 110640 | 0.3998 | 176 |
Top tissues by expression
131 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.97 | gold quality |
| right testis | UBERON:0004534 | 77.60 | gold quality |
| testis | UBERON:0000473 | 76.26 | gold quality |
| left testis | UBERON:0004533 | 75.65 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 73.41 | gold quality |
| bone marrow cell | CL:0002092 | 71.80 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 71.65 | gold quality |
| cortical plate | UBERON:0005343 | 71.18 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 71.12 | gold quality |
| ganglionic eminence | UBERON:0004023 | 69.93 | gold quality |
| metanephros cortex | UBERON:0010533 | 69.15 | gold quality |
| sural nerve | UBERON:0015488 | 68.93 | gold quality |
| muscle tissue | UBERON:0002385 | 68.81 | gold quality |
| muscle of leg | UBERON:0001383 | 68.19 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 68.09 | gold quality |
| lymph node | UBERON:0000029 | 68.07 | gold quality |
| gastrocnemius | UBERON:0001388 | 67.81 | gold quality |
| granulocyte | CL:0000094 | 67.51 | gold quality |
| ventricular zone | UBERON:0003053 | 67.28 | gold quality |
| tonsil | UBERON:0002372 | 66.51 | gold quality |
| substantia nigra | UBERON:0002038 | 66.23 | gold quality |
| heart left ventricle | UBERON:0002084 | 65.48 | gold quality |
| duodenum | UBERON:0002114 | 65.23 | gold quality |
| amygdala | UBERON:0001876 | 65.13 | gold quality |
| mucosa of stomach | UBERON:0001199 | 65.06 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 64.81 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 64.79 | gold quality |
| putamen | UBERON:0001874 | 64.72 | gold quality |
| placenta | UBERON:0001987 | 64.32 | gold quality |
| liver | UBERON:0002107 | 64.26 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.07 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.